Monthly Archives: May 2009

Crohn’s Disease Patients Benefit From Infliximab Plus Azathioprine

The use of infliximab (IFX) plus azathioprine (AZA) and infliximab monotherapy increase the likelihood of patients achieving long-term steroid-free clinical remission in patients with moderate to severe Crohn’s disease, according to a new study. This study represents the first time longer term outcome data has been available to show the advantages of the combination therapy [...]

New Testing for Barrett’s Esophagus Patients

One in five Americans experiences heartburn at least once a week, and many dismiss the malady as a mere annoyance, choosing to swallow antacids and get on with their lives.
But what they don’t know can hurt them. Left untreated, the condition can lead to Barrett’s esophagus, which in turn can put patients at risk for [...]

Improved DNA Stool Test Could Detect Digestive Cancers in Multiple Organs

Mayo Clinic researchers have demonstrated that a noninvasive screening test can detect not only colorectal cancer but also the common cancers above the colon — including pancreas, stomach, biliary and esophageal cancers. This is one of more than 100 Mayo Clinic studies presented at Digestive Disease Week 2009 in Chicago, May 30–June 4.
“Patients are often [...]

Mayo Study Finds That Team Preop Briefing Improves Communication, Reduces Errors

ROCHESTER, Minn. — A short, preoperative team briefing prior to cardiac surgery — where each person on the team speaks — improves communication and reduces errors and costs, according to a pilot study conducted at Mayo Clinic.
Mayo researchers believe this is the first such study to use real-time observations to measure the effect of preoperative [...]

Detection of Bile Duct and Pancreatic Cancers Doubles With New Tests

Pancreatic cancer and bile duct cancer are difficult to diagnose and often fatal because they are discovered in the advanced stages of the disease. Researchers have developed new tests that double the ability to detect bile duct and pancreatic cancers according to a Mayo Clinic study published in the June issue of Gastroenterology.
Pancreatobiliary tumors such [...]

Green Tea may hold future for Leukemia Treatment

Mayo Clinic researchers are reporting positive results in early leukemia clinical trials using the chemical epigallocatechin gallate (EGCG), an active ingredient in green tea. The trial determined that patients with chronic lymphocytic leukemia (CLL) can tolerate the chemical fairly well when high doses are administered in capsule form and that lymphocyte count was reduced in [...]

Mayo Clinic Researchers Find Two Popular Television Shows Inaccurately Portray Realities of Violent Crime

Journalists:  For links to web-video and audio files, see the bottom of this post.
Researchers at Mayo Clinic compared two popular television shows, CSI and CSI: Miami, to actual U.S. homicide data, and discovered clear differences between media portrayals of violent deaths versus actual murders. This study complements previous research regarding media influences on public health [...]

Specialty Care Costs Higher for Patients With Bipolar Disorder Than Diabetes and Other Chronic Diseases

Mayo Clinic researchers have found that bipolar disorder (BPD) is a more costly chronic condition than diabetes, depression, asthma and coronary artery disease (CAD), based on a review of health care claim costs. Specialty care costs (the costs of seeing any specialist and all tests ordered) were especially higher for bipolar patients. Results of this [...]

Mayo Clinic Study May Help Cool Hot Flashes

A pill used for nerve pain offers women relief from hot flashes, Mayo Clinic researchers report at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO).
They say the agent, pregabalin, decreased hot flash severity and frequency about 20 percent more than did a placebo agent. Thus, pregabalin appears to offer about the [...]

Mayo Clinic Researchers Say Drug Shows Dramatic Results in Fight Against Some Thyroid Cancers

A medication that helps stop the growth of new blood vessels has produced dramatic benefits for some patients with aggressive thyroid cancer, research from Mayo Clinic indicates.
At the annual meeting of the American Society of Clinical Oncology (ASCO), Mayo investigators report that cancer in about two-thirds of 37 patients with aggressive differentiated thyroid cancer treated [...]